Skip to main content
. 2016 Mar 18;107(5):601–608. doi: 10.1111/cas.12907

Figure 1.

Figure 1

In vitro cell proliferation and migration assay. Growth (a) and migration (b) of tumor cells in the presence or absence of regorafenib was measured using Incucyte Zoom, which monitors cell confluency in real time. Regorafenib inhibited tumor proliferation and migration irrespective of KRAS and BRAF mutation status. *P < 0.05 versus control.